These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 816655)
61. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. Luo S; Sourla A; Labrie C; Bélanger A; Labrie F Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961 [TBL] [Abstract][Full Text] [Related]
63. Hormonal status and testosterone metabolism of DMBA-induced rat mammary carcinomas. Miller WR Br J Cancer; 1976 Sep; 34(3):296-8. PubMed ID: 823951 [No Abstract] [Full Text] [Related]
64. Plasma estradiol and prolactin levels and their response to stress in two strains of rat with different sensitivities to 7,12-dimethylbenz[a]anthracene-induced tumors. Goldman PR; Vogel WH Cancer Lett; 1985 Jan; 25(3):277-82. PubMed ID: 3918785 [TBL] [Abstract][Full Text] [Related]
65. Alternate fluctuations of leucine and thymidine incorporation by mammary tumors in rats during the estrous cycle. Lee C; Murphy JJ; Diamond CA; Rafferty NS; Oyasu R Cancer Res; 1977 Sep; 37(9):3301-5. PubMed ID: 406988 [No Abstract] [Full Text] [Related]
66. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation. DeSombre ER; Kledzik G; Marshall S; Meites J Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195 [TBL] [Abstract][Full Text] [Related]
67. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964 [TBL] [Abstract][Full Text] [Related]
68. The specificity of the oestrogen receptor of DMBA-induced mammary tumours of the rat. Davies P; Powell-Jones W; Nicholson RI; Griffiths K Eur J Cancer (1965); 1977 Dec; 13(12):1421-7. PubMed ID: 413717 [No Abstract] [Full Text] [Related]
69. Regulatory interrelationships for insulin and estrogen action in mammary tumors. Hilf R; Hissin PJ; Shafie SM Cancer Res; 1978 Nov; 38(11 Pt 2):4076-85. PubMed ID: 100214 [No Abstract] [Full Text] [Related]
71. Antiestrogen-binding sites in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors: relation to growth. Hwang PL; How BE Oncology; 1990; 47(6):495-500. PubMed ID: 2123025 [TBL] [Abstract][Full Text] [Related]
72. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Waseda N; Kato Y; Matsushita N; Imura H Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151 [TBL] [Abstract][Full Text] [Related]
73. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats. Yoshida H; Fukunishi R; Kato Y; Matsumoto K J Natl Cancer Inst; 1980 Oct; 65(4):823-8. PubMed ID: 6775121 [TBL] [Abstract][Full Text] [Related]
74. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro. Wei LL; Mangel WF; Katzenellenbogen BS J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947 [TBL] [Abstract][Full Text] [Related]
75. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors. Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338 [TBL] [Abstract][Full Text] [Related]
76. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas. Rose DP; Fischer AH; Jordan VC Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978 [No Abstract] [Full Text] [Related]
77. Comparative pharmacodynamic analysis of TAT-59 and tamoxifen in rats bearing DMBA-induced mammary carcinoma. Toko T; Shibata J; Sugimoto Y; Yamaya H; Yoshida M; Ogawa K; Matsushima E Cancer Chemother Pharmacol; 1995; 37(1-2):7-13. PubMed ID: 7497599 [TBL] [Abstract][Full Text] [Related]
78. Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth. Winterfeld G; Hauff P; Görlich M; Arnold W; Fichtner I; Staab HJ J Cancer Res Clin Oncol; 1992; 119(2):91-6. PubMed ID: 1429831 [TBL] [Abstract][Full Text] [Related]
79. Metabolism of tamoxifen by isolated rat hepatocytes: anti-estrogenic activity of tamoxifen N-oxide. Bates DJ; Foster AB; Griggs LJ; Jarman M; Leclercq G; Devleeshouwer N Biochem Pharmacol; 1982 Sep; 31(17):2823-7. PubMed ID: 7138577 [No Abstract] [Full Text] [Related]
80. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats. Sylvester PW; Ip C; Ip MM Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]